Peripheral Blood RNAs and Left Ventricular Dysfunction after Myocardial Infarction: Towards Translation into Clinical Practice

Peripheral Blood RNAs and Left Ventricular Dysfunction after Myocardial Infarction: Towards Translation into Clinical Practice

Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction

The Progression of Hypertensive Heart Disease

Signaling cascades in the failing heart and emerging therapeutic strategies

Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development

Frontiers The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction

Frontiers The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review

Peripheral Blood RNAs and Left Ventricular Dysfunction after Myocardial Infarction: Towards Translation into Clinical Practice

Gene Expression Signature in Patients With Symptomatic Peripheral Artery Disease

Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes

Frontiers Renal Denervation Attenuates Adverse Remodeling and Intramyocardial Inflammation in Acute Myocardial Infarction With Ischemia–Reperfusion Injury